Neal James R (CIK 1600865) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-30). Recent activity: Buy PCSA (203 shares), Buy PCSA (789 shares), Buy AKTX (4,464 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | Processa Pharmaceuticals, Inc. (PCSA) | Director | Buy | 203 | $0 |
| 2026-04-02 | Processa Pharmaceuticals, Inc. (PCSA) | Director | Buy | 789 | $2,000 |
| 2025-03-10 | Akari Therapeutics Plc (AKTX) | Director | Buy | 4,464 | $5,000 |
Source: SEC Form 4 filings · as of 2026-06-30